HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Substance-Related Disorders (Drug Abuse)

Disorders related to substance use or abuse.
Also Known As:
Drug Abuse; Substance Abuse; Drug Addiction; Drug Dependence; Substance Dependence; Addiction, Drug; Addiction, Substance; Substance Use Disorder; Substance Use Disorders; Prescription Drug Abuse; Substance Addiction; Abuse, Drug; Abuse, Prescription Drug; Abuse, Substance; Chemical Dependences; Dependence, Chemical; Dependence, Drug; Dependence, Substance; Dependences, Chemical; Disorder, Drug Use; Disorder, Substance Related; Disorder, Substance Use; Disorders, Substance Related; Drug Abuse, Prescription; Habituation, Drug; Organic Mental Disorders, Substance Induced; Related Disorder, Substance; Related Disorders, Substance; Substance Abuses; Substance Uses; Use, Substance; Chemical Dependence; Drug Habituation; Drug Use Disorder; Drug Use Disorders; Organic Mental Disorders, Substance-Induced; Substance Related Disorder; Substance Use
Networked: 21181 relevant articles (785 outcomes, 3076 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Substance-Related Disorders (Drug Abuse)
2. Pain (Aches)
3. Mental Disorders (Mental Disorder)
4. Schizophrenia (Dementia Praecox)
5. Opioid-Related Disorders (Opiate Addiction)

Experts

1. Weiss, Roger D: 55 articles (09/2022 - 02/2003)
2. McCabe, Sean Esteban: 54 articles (01/2022 - 12/2004)
3. Kranzler, Henry R: 54 articles (12/2021 - 01/2002)
4. Degenhardt, Louisa: 53 articles (01/2022 - 03/2003)
5. Wu, Li-Tzy: 50 articles (09/2022 - 03/2003)
6. Gelernter, Joel: 50 articles (12/2021 - 01/2002)
7. Saitz, Richard: 48 articles (07/2022 - 03/2000)
8. Samet, Jeffrey H: 46 articles (12/2022 - 04/2002)
9. Nunes, Edward V: 44 articles (05/2022 - 04/2004)
10. Carroll, Kathleen M: 42 articles (01/2022 - 09/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Substance-Related Disorders:
1. Opioid Analgesics (Opioids)IBA
2. Cocaine (Cocaine HCl)IBA
3. Methadone (Dolophine)FDA LinkGeneric
4. Antipsychotic Agents (Antipsychotics)IBA
5. Hallucinogens (Psychedelics)IBA
6. Buprenorphine (Subutex)FDA LinkGeneric
7. NicotineFDA Link
8. Methamphetamine (Desoxyn)FDA LinkGeneric
9. Heroin (Diamorphine)IBA
10. Antidepressive Agents (Antidepressants)IBA

Therapies and Procedures

1. Therapeutics
01/01/2009 - "Although integrated treatment with the inclusion of cognitive-behavioural therapy, motivational interviewing and family intervention in DD treatment show promising results, it remains to establish which treatment programme is the most qualified in improving mental health and reducing substance use. "
10/01/2005 - "Rigorous research has recently identified a range of behavioral therapies that have been shown to be effective across the most prevalent types of substance dependence. "
04/01/1981 - "However, there was one exception: improvement in psychological function was clearly related to general improvement in most other areas, including chemical abuse, indicating the potential importance of psychologically oriented therapy in substance abuse treatment. "
10/03/2013 - "We found no significant differences on loss to treatment (n = 603, 3 RCTs, RR 1.09 CI 0.82 to 1.45, low quality of evidence), death by 3 years (n = 421, 2 RCTs, RR 1.18 CI 0.39 to 3.57, low quality of evidence), alcohol use (not in remission at 36 months) (n = 143, 1 RCT, RR 1.15 CI 0.84 to 1.56,low quality of evidence), substance use (n = 85, 1 RCT, RR 0.89 CI 0.63 to 1.25, low quality of evidence), global assessment of functioning (n = 171, 1 RCT, MD 0.7 CI 2.07 to 3.47, low quality of evidence), or general life satisfaction (n = 372, 2 RCTs, MD 0.02 higher CI 0.28 to 0.32, moderate quality of evidence).For evaluation of non-integrated intensive case management with usual treatment (4 RCTs, n = 163) we found no statistically significant difference for loss to treatment at 12 months (n = 134, 3 RCTs, RR 1.21 CI 0.73 to 1.99, very low quality of evidence).Motivational interviewing plus cognitive behavioural therapy compared to usual treatment (7 RCTs, total n = 878) did not reveal any advantage for retaining participants at 12 months (n = 327, 1 RCT, RR 0.99 CI 0.62 to 1.59, low quality of evidence) or for death (n = 493, 3 RCTs, RR 0.72 CI 0.22 to 2.41, low quality of evidence), and no benefit for reducing substance use (n = 119, 1 RCT, MD 0.19 CI -0.22 to 0.6, low quality of evidence), relapse (n = 36, 1 RCT, RR 0.5 CI 0.24 to 1.04, very low quality of evidence) or global functioning (n = 445, 4 RCTs, MD 1.24 CI 1.86 to 4.34, very low quality of evidence).Cognitive behavioural therapy alone compared with usual treatment (2 RCTs, n = 152) showed no significant difference for losses from treatment at 3 months (n = 152, 2 RCTs, RR 1.12 CI 0.44 to 2.86, low quality of evidence). "
10/07/2019 - "In comparison to an adolescent substance abuse therapy, one study (112 participants) found significant reduction in re-arrests up to 24 months (MD 0.24, 95% CI 0.76 to 0.28), based on low-certainty evidence.One"
2. Secondary Prevention
3. Drug Therapy (Chemotherapy)
4. Meditation
5. Self Administration (Administration, Self)